Evaluation on Qality of Herbal Medicine Luhui(Aloe)from Different Sites
Objective:To provide a basis for the later development and utilization of herbal medicine Luhui(aloe)by comparing the medicinal quality of 24 herbal medicine aloe samples from different origins.Methods:According to the detection methods and content requirements of Chinese Pharmacopoeia(2020 Edition),the phar-macopeia test items of 24 herbal medicine aloe samples from different origins were determined,including properties,impurities,moisture,total ash,leachables and content determination.Results:The characteristics of imported Luhui(aloe)are mainly irregular blocks,a small number of powders;the surface is tan,rougher and more shiny;the cross-section is tan,smoother and more shiny.The characteristics of domestic Luhui(aloe)are mainly round,the surface is rough,black brown,slightly shiny,the section is rough,black brown,slightly shiny.The impurity content is between 0.00％and 0.05％.The moisture content of 24 batches of aloe vera herbs met the regulations,and the compliance rate was 100.00％.The total ash content of nine batches met the regulations,and the compliance rate was only 37.50％(9/24).The extract content ranged from 2.82％to 93.57％,and the difference was relatively large.Most of the aloe vera content determination does not meet the standards in the Chinese Pharmacopoeia(2020 edition)(aloin content must not be less than 16.00％,Cape of Good Hope aloe vera must not be less than 6.00％),only seven batches of aloin content meets the regulations,and the compliance rate is only 29.17％(7/24).Aloe-emodin could not be detected in 13 batches of samples,and the emodin content of aloe vera in 11 batches ranged from 0.07％to 0.63％.Conclusion:At present,aloe vera in the medicinal materials market is mainly divided into imported and domestic,the quality is uneven,and the quality of imported aloe vera medicinal materials is relatively good,and in the future production and sales process,attention should be paid to strengthening the supervision and management of the initial processing of the place of origin to further improve the quality of medicinal materials.
万方数据
维普
